The present application describes modulators of MCP-1 or CCR-2 of formula
or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein m, n, W, X, R
1
and R
6
, are defined herein. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and transplant rejection using modulators of formula (I) are disclosed.
本申请描述了 MCP-1 或 CCR-2 的调节剂,其
化学式为或其立体异构体或前药或药学上可接受的盐。其中,m、n、W、X、R1 和 R6 在此有定义。此外,本申请还披露了使用化合物 (I) 调节剂治疗和预防炎症性疾病,如哮喘和过敏疾病,以及自身免疫病理学,如类风湿性关节炎和移植排斥等的方法。